The aberrant activation of Nrf2 in cancer cells leads to increased expression of Glucose-6-phosphate dehydrogenase (G6PD), transketolase (TKT), 6-phosphogluconate dehydrogenase (PGD), and other metabolic enzymes promoting glutamine and glucose metabolism in pentose phosphate pathway (PPP) and increasing synthesis of amino acids participating in metabolic reprogramming required for cell proliferation (Mitsuishi et al
Doyle adds context on how oral Wegovy compares with other oral GLP-1s: "In trials, oral Wegovy achieved similar (~15%) weight loss to injectable (~17%)
If the board decides to remove coverage, the benefit would end beginning April 1
Vitamin D Vitamin D receptors are abundant in brain regions tied to attention and mood
Central nervous system-mediated suppression of hepatic glucose production via GLP-1 circuits is noted in murine studies, but less certain in humans [27]
When I do the math described in this topic its not way near, but wondering this might work or not
